These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Intraoperative Low-Dose Dexmedetomidine Administration Associated with Reduced Hepatic Ischemia-Reperfusion Injury in Pediatric Deceased Liver Transplantation: A Retrospective Cohort Study. Zhang L, Li N, Cui LL, Xue FS, Zhu ZJ. Ann Transplant; 2021 Oct 15; 26():e933354. PubMed ID: 34650026 [Abstract] [Full Text] [Related]
23. Correlation of Deceased Donor Factors to Postreperfusion Severe Hyperglycemia in Adult Patients Undergoing Liver Transplant. Milani S, Jafari M, Afzal Aghaee M, Sabzevari A. Exp Clin Transplant; 2021 Oct 15; 19(10):1058-1062. PubMed ID: 34387155 [Abstract] [Full Text] [Related]
27. Postreperfusion Biopsy as a Predictor of Biliary Complication After Deceased Donor Liver Transplantation. A Retrospective Cohort Study. Fuentes-Valenzuela E, Sánchez-Delgado L, Maroto-Martín C, Juan-Casamayor L, Fernández-Prada S, Rodríguez MM, Tejedor-Tejada J, Rubiales BM, Alonso-Martín C, Peñas-Herrero I, Álvarez CA, García-Pajares F. Transplant Proc; 2022 Nov 15; 54(9):2541-2544. PubMed ID: 36273956 [Abstract] [Full Text] [Related]
28. Hemodynamic recovery following postreperfusion syndrome in liver transplantation. Fukazawa K, Yamada Y, Gologorsky E, Arheart KL, Pretto EA. J Cardiothorac Vasc Anesth; 2014 Aug 15; 28(4):994-1002. PubMed ID: 25107717 [Abstract] [Full Text] [Related]
33. Role of the postoperative cholesterol in early allograft dysfunction and survival after living donor liver transplantation. Yang J, Wang HQ, Yang JY, Wen TF, Li B, Wang WT, Yan LN. Hepatobiliary Pancreat Dis Int; 2017 Dec 15; 16(6):610-616. PubMed ID: 29291780 [Abstract] [Full Text] [Related]
34. Portal flow is the main predictor of early graft dysfunction regardless of the GRWR status in living donor liver transplantation - a retrospective analysis of 134 patients. Vasavada BB, Chen CL, Zakaria M. Int J Surg; 2014 Dec 15; 12(2):177-80. PubMed ID: 24370677 [Abstract] [Full Text] [Related]
37. Relationship between the histological appearance of the portal vein and development of ischemic-type biliary lesions after liver transplantation. Farid WR, de Jonge J, Zondervan PE, Demirkiran A, Metselaar HJ, Tilanus HW, de Bruin RW, van der Laan LJ, Kazemier G. Liver Transpl; 2013 Oct 15; 19(10):1088-98. PubMed ID: 23843296 [Abstract] [Full Text] [Related]
38. Incidence and predictors of post-reperfusion syndrome in living donor liver transplantation. Chung IS, Kim HY, Shin YH, Ko JS, Gwak MS, Sim WS, Kim GS, Lee SK. Clin Transplant; 2012 Oct 15; 26(4):539-43. PubMed ID: 22168355 [Abstract] [Full Text] [Related]
39. Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction. Bastos-Neves D, Salvalaggio PRO, Almeida MD. Hepatobiliary Pancreat Dis Int; 2019 Oct 15; 18(5):423-429. PubMed ID: 30853253 [Abstract] [Full Text] [Related]
40. Short-term effects of extracorporeal graft rinse versus circulatory graft rinse in living donor liver transplantation. A prospective randomized controlled trial. Yassen AM, Elsarraf WR, Elmorshedi MA, Abdel Wahab M, Salah T, Sultan AM, Elghawalby AN, Elshobari MM, Elsadany M, Zalata K, Shiha U. Transpl Int; 2017 Jul 15; 30(7):725-733. PubMed ID: 28403531 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]